Qcm Cayman, Ltd. Pfizer Inc Transaction History

Qcm Cayman, Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$25.89 - $29.73 $245,980 - $282,464	9,501 New	9,501 $263,000
Q3 2023 Oct 30, 2023	BUY	$32.09 - $37.51 $208,296 - $243,477	6,491 New	6,491 $215,000
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $229,119 - $339,631	-5,545 Closed	0 $0
Q3 2021 Nov 01, 2021	SELL	$39.25 - $50.42 $52,241 - $67,109	-1,331 Reduced 19.36%	5,545 $238,000
Q2 2021 Aug 10, 2021	BUY	$35.91 - $40.68 $246,917 - $279,715	6,876 New	6,876 $269,000
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $413,536 - $440,871	-12,539 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $400,119 - $464,193	12,539 New	12,539 $445,000

3,260

3.73B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Qcm Cayman, Ltd., based on Form 13F filings with the SEC.

Stay updated on Qcm Cayman, Ltd. with notifications on news.